Biomaterials Product Articles & Analysis
10 news found
CYNK-101 for the Treatment of HER2+ Gastric Cancer: CYNK-101 is a novel allogeneic off-the-shelf human placental CD34+-derived NK cell product candidate that is genetically modified to express high-affinity and cleavage-resistant CD16 (FCGRIIIA) variant to drive antibody-dependent cell-mediated cytotoxicity. ...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy’s proprietary BIOSPHERE® Technology, BIOSPHERE® FLEX SP Extremities is a sheet putty composed of innovative spherical bioactive glass granules combined with a ...
The biomaterials science involves knowledge of multi-disciplines, including medicine, biology, chemistry, tissue engineering and materials science. Either synthetic or natural, biomaterials are often used to augment or replace a natural function mainly in human beings. ...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® MIS II, Next Generation Minimally Invasive Bone Graft Delivery System. Synergy continues to add solutions for surgeons with new innovative biomaterial products to an already successful portfolio. Leveraging off ...
Earlier this month, T,C&A Lab, a branch of Alfa Chemistry, announces to provide biomedical material testing service for customers worldwide who would like to ensure safety and efficacy of their biomaterial products. From a different perspective, laboratory testing is also a must-do step to prove if biomedical materials can meet the regulatory requirements. ...
“Nipple reconstruction has been the limiting factor for a complete breast reconstruction. I’m excited to see this product become available to patients and look forward to offering it to ...
We are committed to continuing to support BioAesthetics' mission of helping patients recover from breast cancer through advancements in biomaterials," said Managing Director of the New Orleans BioFund Kris Khalil. ...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced today that it has received FDA 510(k) clearance of BIOSPHERE® FLEX and is targeting a launch in the 4th quarter of 2018. ...
Amyris, a leading renewable products company, is one of the first commercial-scale second-generation biomaterial producers and is working with a number of partners to deliver products that include renewable fuels and lubricants, high-performance polymers and solvents, and consumer care ingredients such as emollients and fragrance oils. ...
The facility will allow Heraeus PV to offer faster service and customized products for the Taiwanese market. The expansion of the Taiwan facility establishes Heraeus' dedication to the region and the PV industry with plans for continued growth. ...
ByHeraeus